Please assess the completion status of the following clinical trial:

Trial Title: Oral Iron Substitution for Orthopedic Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* age over 55 years~* indication for patient blood management for elective orthopedic surgery~* listed for a orthopedic surgery (e.g. hip or knee replacement) 5-7 weeks after begin of patient blood management~* Haemoglobin male \< 12-13g/dl, female \<11-12g/dl~* written informed consent after written and verbal information~Exclusion Criteria:~* indication for treatment with erythropoietin~* pregnancy~* nursing period~* diarrhea or tendency to diarrhea~* fructose intolerance~* pre - menopause~* permanent or expected blood loss~* participation in other study~* expected compliance problems~* legal incapacity

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OLEOvital (Type: OTHER): 30mg iron are being administered orally twice a day for a period of 4 Weeks it is a granulated powder which is taken orally and then solved with saliva, without taking water

Based on this trial design, predict the completion outcome and termination type (if applicable).